Newly uncovered enzyme mechanism could help target drug-resistant breast cancer
One of the major challenges in treating the most common subtype of breast cancer (hormone receptor positive, HR+) is the emergence of resistance to treatment. In a recent study, Boston Children's Hospital researchers and ...
Sep 30, 2026
0
5









